DU145, LNCaP, MR49F, and V16D cells were cultured in RPMI-1640 medium. MR49F and V16D cells were kindly provided by Dr. Amina Zoubeidi (Vancouver Prostate Centre, University of British Columbia, BC, Canada) [38]. VCaP and PC3 cells were cultured in DMEM and MEM medium, respectively. All cells were passaged in media containing 10% FBS (GibcoTM, Thermo Fisher Scientific, Waltham, MA, USA). Additionally, V16D and MR49F cells are supplemented with 1 mM sodium pyruvate. MR49F cells were maintained in media with 10 μM enzalutamide.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.